Thus, we speculate that LTA4H not only participates in the regulation of cancer through the inflammatory mediator pathway, but also controls the expression of cancer key genes by interacting with mRNA at the transcriptional or post-transcriptional level. The gene discussed is LTA4H; the disease is cancer.